サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1750736

造影超音波市場の市場規模、シェア、動向分析レポート：製品別、タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

Contrast Enhanced Ultrasound Market Size, Share & Trends Analysis Report By Product (Equipment, Contrast Agents), By Type (Non-targeted, Targeted), By End Use (Hospitals, Clinics), By Region (North America, Europe), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 130 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.50円
造影超音波市場の市場規模、シェア、動向分析レポート：製品別、タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年05月12日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

造影超音波市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、造影剤強化超音波の世界市場は2030年までに29億9,000万米ドルに達し、予測期間中にCAGR 5.8％で成長すると予測されています。

がん、心血管疾患、肝疾患などの慢性疾患の有病率の増加が、正確で早期診断の需要を促進しています。患者や臨床医は、安全性、迅速性、放射線被曝の少なさから、造影超音波（CEUS）のような非侵襲的手技をますます好むようになっています。このような嗜好の高まりと継続的な疾患モニタリングの必要性から、世界のヘルスケアシステムでCEUS技術が急速に採用され、市場規模と臨床利用が拡大しています。

ヘルスケア・インフラへの世界の投資がCEUSのような先進診断ツールの採用に拍車をかけています。近代的な病院や診断センターでは、患者ケアを向上させるためにCEUSシステムの導入が進んでいます。加えて、高齢化により定期的な画像診断を必要とする慢性疾患が急増しています。このような人口動態やインフラの動向はCEUSの需要を大幅に増加させ、CEUSは世界的に最新の診断戦略に不可欠な要素となっています。

超音波技術と造影剤開発における継続的な技術革新は、CEUSの精度、効率、安全性を向上させています。このような改良により、CEUSは腫瘍学、心臓病学、腎臓病学など多くの医療分野で応用が広がっています。様々な臓器のリアルタイムで詳細な画像診断が可能なCEUSは、より迅速で十分な情報に基づいた臨床判断をサポートします。このような多様な診断領域への拡大により、広範な採用が促進され、今後数年間の市場成長が期待されます。

造影超音波市場のレポートハイライト

  • 製品別では、装置分野が2024年に71.7%の最大シェアを占めました。これは、高度な超音波システムの採用が増加し、精密な診断ツールに対する需要が高まっているためです。
  • 造影剤セグメントは、慢性疾患の有病率の上昇と非侵襲的診断手順に対する意識の高まりに後押しされ、2025年から2030年にかけて最も急成長すると予測されます。
  • タイプ別では、非標的セグメントが2024年に最大の収益シェアで市場をリードしました。
  • 最終用途別では、患者数の多さ、高度な画像技術へのアクセス、熟練した専門家の利用可能性などから、病院セグメントが2024年に最大のシェアを獲得して市場を独占しました。
  • 北米は、2024年に34.6％の最大売上シェアを占めました。これは、確立されたヘルスケアインフラ、先進画像技術の普及、CEUS手技に対する有利な償還政策に後押しされました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 造影超音波市場の変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 造影超音波市場分析ツール
    • 業界分析 - ポーターのファイブフォース分析
    • PESTLE分析

第4章 造影超音波市場：製品推定・動向分析

  • 製品セグメントダッシュボード
  • 造影超音波市場：製品変動分析
  • 世界の造影超音波市場規模と動向分析（製品別、2018～2030年）
  • 装置
  • 造影剤

第5章 造影超音波市場：タイプ別推定・動向分析

  • タイプセグメントダッシュボード
  • 造影超音波市場：タイプ変動分析
  • 世界の造影超音波市場規模と動向分析（タイプ別、2018～2030年）
  • 非標的型
  • 標的型

第6章 造影超音波市場：最終用途推定・動向分析

  • 最終用途セグメントダッシュボード
  • 造影超音波市場：エンドユーザー変動分析
  • 世界の造影超音波市場規模と動向分析（最終用途別、2018～2030年）
  • 病院
  • クリニック
  • 外来診断センター

第7章 造影超音波市場：地域推定・動向分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 地域別造影超音波市場：主なポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • Key Company Heat Map Analysis, 2024
  • 企業プロファイル
    • Lantheus
    • GE HealthCare
    • Bracco
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Contrast Enhanced Ultrasound Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 North America Contrast Enhanced Ultrasound Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 North America Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Mexico Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Contrast Enhanced Ultrasound Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Europe Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 UK Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 UK Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Germany Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 France Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 France Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Italy Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Spain Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 Denmark Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Sweden Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Sweden Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Norway Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Norway Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Contrast Enhanced Ultrasound Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 Japan Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Japan Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55 China Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 China Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 China Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58 India Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 India Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Australia Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 South Korea Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 Thailand Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Contrast Enhanced Ultrasound Market, By Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 Latin America Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 Brazil Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 Argentina Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Contrast Enhanced Ultrasound Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 85 South Africa Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 91 UAE Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Contrast Enhanced Ultrasound Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Contrast Enhanced Ultrasound Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Contrast Enhanced Ultrasound Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Contrast Enhanced Ultrasound Market: Market Outlook
  • Fig. 10 Contrast Enhanced Ultrasound Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Contrast Enhanced Ultrasound Market Driver Impact
  • Fig. 16 Contrast Enhanced Ultrasound Market Restraint Impact
  • Fig. 17 Contrast Enhanced Ultrasound Market Strategic Initiatives Analysis
  • Fig. 18 Contrast Enhanced Ultrasound Market: Product Movement Analysis
  • Fig. 19 Contrast Enhanced Ultrasound Market: Product Outlook and Key Takeaways
  • Fig. 20 Equipment Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Contrast Agents Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Contrast Enhanced Ultrasound Market: Type Movement Analysis
  • Fig. 23 Contrast Enhanced Ultrasound Market: Type Outlook and Key Takeaways
  • Fig. 24 Non-targeted Market, 2018-2030 (USD Million)
  • Fig. 25 Targeted Market, 2018-2030 (USD Million)
  • Fig. 26 Contrast Enhanced Ultrasound Market: End Use Movement Analysis
  • Fig. 27 Contrast Enhanced Ultrasound Market: End Use Outlook and Key Takeaways
  • Fig. 28 Hospitals Market, 2018-2030 (USD Million)
  • Fig. 29 Clinics Market, 2018-2030 (USD Million)
  • Fig. 30 Ambulatory Diagnostic Centers Market, 2018-2030 (USD Million)
  • Fig. 31 Global Contrast Enhanced Ultrasound Market: Regional Movement Analysis
  • Fig. 32 Global Contrast Enhanced Ultrasound Market: Regional Outlook and Key Takeaways
  • Fig. 33 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68039-141-1

Contrast Enhanced Ultrasound Market Growth & Trends:

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030 and grow at a CAGR of 5.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, cardiovascular, and liver disorders drives the demand for accurate and early diagnosis. Patients and clinicians increasingly favor noninvasive procedures like Contrast Enhanced Ultrasound (CEUS) due to their safety, speed, and lack of radiation exposure. This growing preference and the need for ongoing disease monitoring fuel rapid adoption of CEUS technologies across global healthcare systems, thereby expanding market size and clinical utilization.

Global investments in healthcare infrastructure fuel the adoption of advanced diagnostic tools like CEUS. Modern hospitals and diagnostic centers are increasingly equipping themselves with CEUS systems to improve patient care. In addition, an aging population contributes to a surge in chronic conditions that require regular imaging. These demographic and infrastructure trends are significantly increasing the demand for CEUS, making it a vital component of modern diagnostic strategies worldwide.

Ongoing innovations in ultrasound technology and contrast agent development enhance the accuracy, efficiency, and safety of CEUS. These improvements have broadened CEUS applications across multiple medical fields, including oncology, cardiology, and nephrology. The ability to use CEUS for real-time, detailed imaging in various organs supports faster, more informed clinical decisions. This expansion into diverse diagnostic areas is expected to drive widespread adoption and boost market growth over the coming years.

Contrast Enhanced Ultrasound Market Report Highlights:

  • By product, the equipment segment held the largest share of 71.7% in 2024 due to the rising adoption of advanced ultrasound systems and increasing demand for precise diagnostic tools.
  • The contrast agents segment is anticipated to be the fastest-growing segment from 2025 to 2030,fueled bythe rising prevalence of chronic diseases and growing awareness of noninvasive diagnostic procedures.
  • By type, the non-targeted segment led the market with the largest revenue share in 2024, attributed to its broad clinical applicability and ease of use.
  • By end use, the hospitals segment dominated the market with the largest share in 2024, owing to high patient volumes, access to advanced imaging technologies, and the availability of skilled professionals.
  • North America accounted for the largest revenue share of 34.6% in 2024, propelled bya well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and favorable reimbursement policies for CEUS procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Type Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Contrast Enhanced Ultrasound Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Contrast Enhanced Ultrasound Market: Product Movement Analysis
  • 4.3. Global Contrast Enhanced Ultrasound Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Contrast Agents
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Contrast Enhanced Ultrasound Market: Type Movement Analysis
  • 5.3. Global Contrast Enhanced Ultrasound Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 5.4. Non-targeted
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Targeted
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Contrast Enhanced Ultrasound Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Contrast Enhanced Ultrasound Market: End Use Movement Analysis
  • 6.3. Global Contrast Enhanced Ultrasound Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Ambulatory Diagnostic Centers
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Contrast Enhanced Ultrasound Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. U.K.
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/ Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Lantheus
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. GE HealthCare
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Bracco
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Siemens Healthineers AG
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Koninklijke Philips N.V.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. CANON MEDICAL SYSTEMS CORPORATION
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives